BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/1/2014 11:02:00 AM | Browse: 1230 | Download: 808
 |
Received |
|
2013-09-28 19:05 |
 |
Peer-Review Started |
|
2013-09-29 16:18 |
 |
To Make the First Decision |
|
2013-12-16 17:07 |
 |
Return for Revision |
|
2013-12-17 15:23 |
 |
Revised |
|
2014-01-13 23:04 |
 |
Second Decision |
|
2014-02-20 15:31 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2014-02-20 15:56 |
 |
Articles in Press |
|
|
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2014-03-07 17:18 |
 |
Publish the Manuscript Online |
|
2014-03-27 12:04 |
Category |
Gastroenterology & Hepatology |
Manuscript Type |
Topic Highlights |
Article Title |
Biomarkers in inflammatory bowel diseases: Current status and proteomics identification strategies
|
Manuscript Source |
Invited Manuscript |
All Author List |
Tue Bennike, Svend Birkelund, Allan Stensballe and Vibeke Andersen |
Funding Agency and Grant Number |
|
Corresponding Author |
Vibeke Andersen, MD, PhD, Organ Center, Hospital of Southern Jutland, Kresten Philipsens Vej 15, 6200 Aabenraa, Denmark. vibeke.andersen1@rsyd.dk |
Key Words |
Inflammatory bowel disease; Biomarker; Proteomics; Citrullination; Ulcerative colitis; Crohn’s disease; Posttranslational modification |
Core Tip |
Establishing the correct diagnose of Crohn’s disease and ulcerative colitis (UC) patients remains troublesome, and correct and early medication is critical. No reliable biomarkes have been implemented in clinical usage, to distinguish between Crohn’s disease patients and UC patients. Considering the protein complexity encountered in intestinal biopsy samples and the recent development within the field of quantitative proteomics, submitting the intestinal mucosa to a more thorough analysis has the potential to reveal new biomarkers. |
Publish Date |
2014-03-27 12:04 |
Citation |
Bennike T, Birkelund S, Stensballe A, Andersen V. Biomarkers in inflammatory bowel diseases: Current status and proteomics identification strategies. World J Gastroenterol 2014; 20(12): 3231-3244 |
URL |
http://www.wjgnet.com/1007-9327/full/v20/i12/3231.htm |
DOI |
http://dx.doi.org/10.3748/wjg.v20.i12.3231 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345